SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551986-19-000109
Filing Date
2019-10-07
Accepted
2019-10-07 06:59:59
Documents
5
Period of Report
2019-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kmergeragreement.htm 8-K 86804
2 EXHIBIT 2.1 a21mergeragreement.htm EX-2.1 1212756
3 EXHIBIT 10.1 a101formofsupportagreemnt.htm EX-10.1 116975
4 EXHIBIT 10.2 a102formoflockupagreement.htm EX-10.2 16571
5 EXHIBIT 99.1 a991pressrelease10719.htm EX-99.1 27486
  Complete submission text file 0001551986-19-000109.txt   1461971
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37797 | Film No.: 191139627
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences